XML 31 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Note 1 - Description of Business, Basis of Presentation and Going Concern (Details Textual)
3 Months Ended
Apr. 21, 2020
USD ($)
Jun. 04, 2019
shares
Jan. 01, 2019
USD ($)
Mar. 31, 2019
USD ($)
Sep. 30, 2020
USD ($)
shares
Jun. 30, 2020
Apr. 28, 2020
USD ($)
Dec. 31, 2019
USD ($)
shares
Nov. 26, 2019
USD ($)
Mar. 31, 2017
USD ($)
Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance         $ 170,000     $ 530,000    
Reorganization of Subsidiary and Related Change in Non-controlling Interest                  
Common Stock, Shares Authorized (in shares) | shares   350,000,000     350,000,000     350,000,000    
Notes Payable, Current, Total         $ 235,000        
Notes Payable, Noncurrent, Total         411,000     1,000,000    
Cash and Cash Equivalents, at Carrying Value, Ending Balance         4,436,000     3,157,000    
Working Capital         7,056,000          
Retained Earnings (Accumulated Deficit), Ending Balance         (250,434,000)     $ (236,932,000)    
Paycheck Protection Program CARES Act [Member]                    
Proceeds from Issuance of Long-term Debt, Total $ 646,000                  
Notes Payable, Current, Total         235,000          
Notes Payable, Noncurrent, Total         411,000          
Boyalife Investment Fund II, Inc. [Member] | Revolving Credit Facility [Member]                    
Line of Credit Facility, Maximum Borrowing Capacity         10,000,000         $ 10,000,000
Long-term Line of Credit, Total         $ 10,000,000   $ 10,000,000      
Reverse Stock Split [Member]                    
Stockholders' Equity Note, Stock Split, Conversion Ratio   10                
ImmuneCyte [Member]                    
Equity Method Investment, Ownership Percentage         18.79%       20.00%  
Line of Credit Facility, Maximum Borrowing Capacity                 $ 1,000,000  
ImmuneCyte [Member] | HealthBanks Biotech [Member]                    
Equity Method Investment, Ownership Percentage         75.16%       80.00%  
Noncontrolling Interest [Member]                    
Reorganization of Subsidiary and Related Change in Non-controlling Interest     $ 2,843,000 $ 2,843,000            
CAR-TXpress [Member]                    
Noncontrolling Interest, Ownership Percentage by Parent     80.00%   80.00% 80.00%        
Minority Interest Acquired Through Exchange     20.00%              
Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance     $ 1,100,000              
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners           20.00%        
ThermoGenesis [Member]                    
Noncontrolling Interest, Ownership Percentage by Parent     100.00%              
Ownership in Subsidiary Exchanged     20.00%              
Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance     $ (1,711,000)